Application Nr Approved Date Route Status External Links
NDA203971 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Xofigo Is Indicated For The Treatment Of Patients With Castration-Resistant Prostate Cancer, Symptomatic Bone Metastases And No Known Visceral Metastatic Disease. Xofigo Is An Alpha Particle-Emitting Radioactive Therapeutic Agent Indicated For The Treatment Of Patients With Castration-Resistant Prostate Cancer, Symptomatic Bone Metastases And No Known Visceral Metastatic Disease. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Radium Ra-223 Dichloride

Comments